Fresenius Medical Care (FMS) Competitors

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, community ranking, dividends and media sentiment.

Does the MarketBeat Community favor NTRA or FMS?

Natera received 68 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 491 68.96%	Underperform Votes 221 31.04%
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%

Which has higher earnings & valuation, NTRA or FMS?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.70B	12.53	-$434.80M	-$1.53	-102.78
Fresenius Medical Care	$19.34B	0.78	$540.07M	$0.99	25.99

Do analysts prefer NTRA or FMS?

Natera presently has a consensus price target of $175.76, suggesting a potential upside of 11.78%. Fresenius Medical Care has a consensus price target of $25.30, suggesting a potential downside of 1.66%. Given Natera's stronger consensus rating and higher possible upside, equities analysts plainly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media favor NTRA or FMS?

In the previous week, Natera had 17 more articles in the media than Fresenius Medical Care. MarketBeat recorded 22 mentions for Natera and 5 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.71 beat Natera's score of 1.15 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	16 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility and risk, NTRA or FMS?

Natera has a beta of 1.8, indicating that its stock price is 80% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.

Is NTRA or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Fresenius Medical Care	3.43%	6.04%	2.69%

Do insiders & institutionals believe in NTRA or FMS?

99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Natera beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks.